The Expression of IL-17a Was Obviously Upregulated in the Plasma, Peripheral Blood Monocytes, and Sputum of COPD Patients in the Exacerbation-Month12 Group
(A) The expression of IL-17a was enhanced in the plasma of COPD patients in the exacerbation-month12 group. (B) The expression of IL-17a was enhanced in the peripheral blood monocytes of COPD patients in the exacerbation-month12 group. (C) The expression of IL-17a was enhanced in the sputum of COPD patients in the exacerbation-month12 group.